We are inviting you to take part in a research study for children and adolescents, aged 5-17, with Autism Spectrum Disorder (ASD). All study-related care will be provided at no cost. No health insurance is required to participate. In addition, compensation for time and travel may be provided.
The rainbow study will enroll about 152 children and adolescents, aged 5-17, with Autism Spectrum Disorder (ASD) at approximately 40 study sites throughout the US.
The rainbow study is evaluating if an investigational drug is safe and able to reduce irritability in children and adolescents, aged 5-17, with Autism Spectrum Disorder (ASD).
Your child may qualify for the rainbow study if they:
What happens if I sign up? We will match you to a study site in your area that needs pediatric patients with Autism Spectrum Disorder (ASD) or notify you when one becomes available. The study staff will then contact you and your child may have the opportunity to participate if qualified.
If you are interested in having your child participate in the rainbow study or would like more information, please complete the questions below so we can see if your child may qualify and can contact you about the studies. Keep in mind that participation is entirely voluntary. If you and your child do decide to take part in this study, you may change your mind about participating at any time.
Autism, also known as Autism Spectrum Disorder (ASD), is a common and complex developmental condition that is estimated to affect 1 in 59 children in the US pediatric population.1
ASD is often characterized by core features and characteristics that include*:
A research study (also called a clinical trial) is a medical study that helps to answer important questions about an investigational drug – these may include how well an investigational study drug works for a certain condition. All medications must be tested in clinical research studies before they can be approved and prescribed to patients.
A research study is a key component in the process of researching and developing potential new medical treatments. Research studies aim primarily to evaluate the safety and efficacy of potential new treatments.
The purpose of the rainbow study is to see if the investigational drug is safe and able to reduce irritability in children and adolescents, aged 5-17, with ASD.
The rainbow study will enroll about 152 children and adolescents, aged 5-17, with Autism Spectrum Disorder (ASD) at approximately 40 study sites throughout the US.
The study will include approximately 9 visits to a study site in your location over approximately 20 weeks.
This research study includes 5 study periods. Each study period includes different activities.
Volunteers who qualify to take part in the study may receive compensation. Please discuss this with the study team when they contact you.
There is no cost to participate in the rainbow study. If you decide to take part:
The research team will be able to explain more about what the rainbow study will involve, and it is up to you and your child to decide to take part. Participation in this study is voluntary. Whether or not your child decides to participate in this study will not affect their current or future relationships with their doctors. If you and your child decide to participate, you are free to withdraw at any time without affecting those relationships.
We match you and your child to a site within a close travel distance from your home. If we are not running the study in your area currently, with your permission, we will keep you in our database and reach out once a study in your area becomes available. If, at any time, you decided you no longer want your information stored, you can opt out and we will delete your details.
The rainbow study will enroll about 152 children and adolescents, aged 5-17, with Autism Spectrum Disorder (ASD) at approximately 40 study sites throughout the US.
The study will include approximately 9 visits to a study site in your location over approximately 20 weeks.
Participants will receive all study-related care from a dedicated medical team at no cost.
Those who qualify to take part in the study may receive compensation for time and travel.
The rainbow study is evaluating an investigational drug to see if it is safe and able to reduce irritability in children and adolescents, aged 5-17, with Autism Spectrum Disorder (ASD).
Your child may qualify for the rainbow study if they:
All study-related care will be provided at no cost.